Provided by Tiger Trade Technology Pte. Ltd.

GlaxoSmithKline PLC

50.29
+0.28000.56%
Pre-market: 50.540.2500+0.50%09:13 EDT
Volume:2.84M
Turnover:143.00M
Market Cap:101.72B
PE:16.08
High:50.71
Open:50.19
Low:50.06
Close:50.01
52wk High:61.70
52wk Low:39.29
Shares:2.02B
Float Shares:1.94B
Volume Ratio:1.13
T/O Rate:0.15%
Dividend:1.82
Dividend Rate:3.62%
EPS(TTM):3.13
EPS(LYR):3.74
ROE:33.38%
ROA:10.01%
PB:4.31
PE(LYR):13.46

Loading ...

GSK, Sino Biopharmaceutical Unit Expand Collaboration to Cover Two GSK Respiratory Therapies

MT Newswires Live
·
Jul 08

Barclays Remains a Sell on GlaxoSmithKline (GSK)

TIPRANKS
·
Jul 08

Dow Jones Top Company Headlines at 3 am ET: Sino Biopharm Strikes Drug Licensing Deal with Astrazeneca, Deepens GSK Partnership | White ...

Dow Jones
·
Jul 08

Sino Biopharm Deepens GSK Respiratory Deal to Cement China Lead

TIPRANKS
·
Jul 08

GSK’s StrateGIST Frontline Trial Puts New Cancer Drug Velzatinib in the Spotlight

TIPRANKS
·
Jul 08

Drug Pricing Pressure Puts GSK And Global Pharma Stocks In Focus

Simply Wall St.
·
Jul 07

GSK Falls Monday, Underperforms Market

Dow Jones
·
Jul 07

Pharmaceutical Sector Attracts Capital Rotation, GlaxoSmithKline Surges Nearly 5%

Stock News
·
Jul 02

Movement Alert|GSK Rises 3.02% in Regular Trading, Pharma Sector Rallies as Nuvalent Tender Offer Advances

Market Focus
·
Jul 02

GSK Slides Wednesday, Underperforms Market

Dow Jones
·
Jul 02

GSK’s New mRNA Combo Shot Targets Flu and COVID-19 in One Vaccine

TIPRANKS
·
Jul 01

GSK: Neutral Stance Maintained as Near-Term Strength Offsets Pipeline and Litigation Risks; Price Target Held at £2,350

TIPRANKS
·
Jun 30

Goldman Sachs Sticks to Their Hold Rating for GlaxoSmithKline (GSK)

TIPRANKS
·
Jun 30

GSK Completes £2 Billion Share Buyback, Lifts Treasury Holdings to 6.7% of Voting Rights

TIPRANKS
·
Jun 29

J.P. Morgan Reaffirms Their Sell Rating on GlaxoSmithKline (GSK)

TIPRANKS
·
Jun 29

GlaxoSmithKline (GSK) Gets a Sell from Barclays

TIPRANKS
·
Jun 29

GSK’s Extended Salford Lung Study: What a Terminated Data Project Still Means for Investors

TIPRANKS
·
Jun 27

Dodge & Cox lifts GSK stake above 5% as institutional backing grows

TIPRANKS
·
Jun 26

GSK Advances BALANCE Trial: New IBS Drug Candidate Moves Through Mid‑Stage Testing

TIPRANKS
·
Jun 26

GSK’s MODIFY Asthma Trial: Early Biologic Bet With Long-Term Upside Potential

TIPRANKS
·
Jun 26